Neopterin: A Key Biomarker for Cellular Immune System Activation

Neopterin, an organic compound belonging to the pteridine class of heterocyclic compounds, has emerged as an important biomarker in the field of immunology and disease research. It is synthesized by human macrophages upon stimulation with interferon-gamma (IFN-γ), a cytokine involved in the regulation of the immune response. Neopterin serves as an indicator of cellular immune system activation and plays a critical role in understanding various diseases and their progression.

Browse all Microcystin products

Properties and Biosynthesis of Neopterin

Neopterin, chemically known as 2-Amino-6-(1,2,3-trihydroxypropyl)pteridin-4(1H)-one, has a molecular formula of C₉H₁₁N₅O₄ and a molecular weight of 253.215 g/mol. It exhibits a density of 2.02 g/cm³ and exists as a white crystalline powder. Neopterin belongs to the chemical group known as pteridines and is produced through a two-step biosynthesis process.

The biosynthesis of neopterin begins with guanosine triphosphate (GTP) as the precursor molecule. The first step involves the enzymatic activity of GTP cyclohydrolase, which opens the ribose group, leading to the formation of the intermediate compound. Subsequently, phosphatases catalyze the hydrolysis of the phosphate ester group, resulting in the formation of neopterin.

Neopterin as a Diagnostic Biomarker

Neopterin has gained significant attention as a valuable disease marker of monocyte/macrophage axis activation in certain clinical situations. Measurement of neopterin concentrations in body fluids, including blood serum, cerebrospinal fluid (CSF), or urine, provides critical information about the extent and activity of several diseases involving activation of the cellular immune system, such as certain cancers, organ transplant rejection, autoimmune diseases, and viral infections.

• Infectious Diseases
  High neopterin levels predict HIV-related mortality and decrease with effective antiretroviral therapy. In addition, elevated neopterin levels are associated with hepatitis due to hepatitis A, B, and C viruses and may predict treatment response in chronic HCV infection. In pulmonary tuberculosis, higher neopterin levels correlate with more extensive radiologic changes. Neopterin measurement has been used to screen out blood donors at risk of transmitting viral infections. Overall, neopterin serves as a non-specific marker of immune response and may help monitor infectious disease activity, determine disease extent, and predict prognosis.
• Autoimmune Diseases
  Elevated neopterin levels have been observed in several autoimmune diseases, including rheumatoid arthritis, Crohn's disease, systemic lupus erythematosus, and ulcerative colitis. Neopterin levels correlate with disease activity, laboratory data, clinical findings, and response to treatment. This suggests that measurement of neopterin may be useful in predicting prognosis and monitoring patients with autoimmune diseases.
• Neuroinflammatory Diseases
  Neopterin serves as a biomarker for immune-inflammatory conditions and can increase oxidative stress to fight infection. It also provides cytoprotection in non-immune cells and has various biological effects, such as influencing gene expression and cell viability. Elevated CSF neopterin levels are observed in acute viral and bacterial infections, chronic neuroinflammatory diseases, and other conditions. A proposed cut-off of 61 nmol/L helps to distinguish inflammatory from non-inflammatory conditions in pediatric populations. However, neopterin alone may not be sufficient to differentiate between different causes of neuroinflammation.
• Malignant Tumor Diseases
  In various types of cancer, neopterin levels in body fluids such as urine, serum/plasma, or ascites correspond to the progression of the disease. Higher neopterin concentrations in patients independently predict shorter survival. Neopterin levels in both peripheral blood and the tumor microenvironment are associated with changes in the function and characteristics of lymphocytes, indicating immune dysfunction. Higher neopterin concentrations coincide with the increased conversion of tryptophan to kynurenine. Additionally, elevated neopterin levels are linked to side effects of anticancer treatments and could potentially predict complications.
  Measuring neopterin not only aids in laboratory diagnostics but also provides insights into immune activation status and its interaction with tumor development. It helps understand how immune activation contributes to tumor-induced immune escape and tolerance to tumor antigens.
• Renal Allograft Rejection
  Neopterin has been studied as a potential diagnostic biomarker for renal allograft rejection, which refers to the immune response against a transplanted kidney. The levels of neopterin have been found to increase during episodes of rejection and may serve as an indicator of immune activation in this context. Monitoring neopterin concentrations can contribute to the early detection and management of rejection episodes, improving patient outcomes.

Neopterin-Related Antibodies

Neopterin-Related Antigens

Neopterin-Related ELISA Kits